Recognition highlights Prenosis’ leadership in integrated diagnostics and therapeutics and its mission to bring clarity to critical care decisions

CHICAGO, IL – September 15, 2025 – Prenosis has been selected as a quarterfinalist for the 2025 Digital Health Hub Foundation Digital Health Awards in the AI-Driven Diagnostics in Acute Care category.

This recognition underscores Prenosis’ commitment to advancing AI-enabled, integrated diagnostics and therapeutics that provide clearer insights when decisions matter most. The Digital Health Hub Awards celebrate organizations using digital innovation to improve the speed, efficiency, and equity of healthcare.

Prenosis earned this honor for its FDA De Novo-authorized technology, Sepsis ImmunoScore™, built on the company’s Immunix™ precision medicine platform. Sepsis ImmunoScore combines biomarkers and clinical data to generate predictive insights that help clinicians navigate uncertainty in acute care.

“We are honored to be named a quarterfinalist for the 2025 Digital Health Awards,” said Bobby Reddy, Jr., PhD, co-founder and CEO of Prenosis. “This recognition reflects our mission to bring deeper biological insight to the healthcare community and to support more confident, proactive decision-making.”

From over 1,800 submissions, only 16 quarterfinalists per category advanced to this stage.

“The 2025 Awards have once again raised the bar, drawing an unprecedented range of global submissions that highlight the rapid evolution of AI and the impact of digital health,” said Mark H. Goldstein, chairman of the Digital Health Hub Foundation. “Congratulations to all of our quarterfinalists for pushing the boundaries of what’s possible and driving meaningful change in healthcare.”

 

ABOUT PRENOSIS, INC. 

Prenosis, Inc. is a biology-based technology company redefining the standard of care for critical conditions. We believe healthcare should not follow a one-size-fits-all model. Instead, our mission is to tailor healthcare to each patient’s biology through the creation and delivery of integrated diagnostics and therapeutics. We use deep data and AI to build tools that augment clinical diagnosis of critical conditions based on each patient’s unique biological profile. Unlike other AI-driven diagnostics, we go further by developing therapies that help providers deliver personalized care. Our Immunix™ platform powers the development of a variety of AI-based diagnostics, including Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic tool for sepsis. At Prenosis, we see people differently. For more information, visit us on LinkedIn.

 

ABOUT DIGITAL HEALTH HUB FOUNDATION 

Founded in 2017 on the UCSF campus in San Francisco, the Digital Health Hub Foundation helps the world’s most innovative healthcare companies scale and grow. Its 30,000-member community includes early- to late-stage healthcare companies, providers, payors, mentors, investors, clinicians, and researchers. Each year, the Foundation’s awards program recognizes organizations making the most significant contributions to advancing healthcare through digital innovation.